iShares Genomics Immunology and Healthcare ETF (IDNA)
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
$143.73M
Jun 11, 2019
2.45
$10.25
0.00
0.00
3.44%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (30)
Gilead Sciences, Inc.
GILD
4.893%
Exelixis, Inc.
EXEL
4.697%
Regeneron Pharmaceuticals, Inc.
REGN
4.612%
Sarepta Therapeutics, Inc.
SRPT
4.359%
Revolution Medicines, Inc.
RVMD
4.308%
Incyte Corporation
INCY
4.277%
Merck & Co., Inc.
MRK
3.647%
Arcellx, Inc.
ACLX
3.168%
SpringWorks Therapeutics, Inc.
SWTX
2.966%
Iovance Biotherapeutics, Inc.
IOVA
2.628%
Twist Bioscience Corporation
TWST
2.503%
Geron Corporation
GERN
2.407%
Beam Therapeutics Inc.
BEAM
2.086%
Ligand Pharmaceuticals Incorporated
LGND
2.035%
Moderna, Inc.
MRNA
1.955%
BioCryst Pharmaceuticals, Inc.
BCRX
1.81%
Novavax, Inc.
NVAX
1.79%
Dynavax Technologies Corporation
DVAX
1.584%
Nurix Therapeutics, Inc.
NRIX
1.56%
Blueprint Medicines Corporation
BPMC
1.41%
Arcus Biosciences, Inc.
RCUS
0.87%
Vir Biotechnology, Inc.
VIR
0.762%
4D Molecular Therapeutics, Inc.
FDMT
0.757%
ImmunityBio, Inc.
IBRX
0.598%
Arcturus Therapeutics Holdings Inc.
ARCT
0.519%
Intellia Therapeutics, Inc.
NTLA
0.498%
OmniAb, Inc.
OABI
0.439%
Editas Medicine, Inc.
EDIT
0.322%
Ginkgo Bioworks Holdings, Inc.
DNA
0.242%
MacroGenics, Inc.
MGNX
0.221%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (30)
Gilead Sciences, Inc.
GILD
4.893%
Exelixis, Inc.
EXEL
4.697%
Regeneron Pharmaceuticals, Inc.
REGN
4.612%
Sarepta Therapeutics, Inc.
SRPT
4.359%
Revolution Medicines, Inc.
RVMD
4.308%
Incyte Corporation
INCY
4.277%
Merck & Co., Inc.
MRK
3.647%
Arcellx, Inc.
ACLX
3.168%
SpringWorks Therapeutics, Inc.
SWTX
2.966%
Iovance Biotherapeutics, Inc.
IOVA
2.628%
Twist Bioscience Corporation
TWST
2.503%
Geron Corporation
GERN
2.407%
Beam Therapeutics Inc.
BEAM
2.086%
Ligand Pharmaceuticals Incorporated
LGND
2.035%
Moderna, Inc.
MRNA
1.955%
BioCryst Pharmaceuticals, Inc.
BCRX
1.81%
Novavax, Inc.
NVAX
1.79%
Dynavax Technologies Corporation
DVAX
1.584%
Nurix Therapeutics, Inc.
NRIX
1.56%
Blueprint Medicines Corporation
BPMC
1.41%
Arcus Biosciences, Inc.
RCUS
0.87%
Vir Biotechnology, Inc.
VIR
0.762%
4D Molecular Therapeutics, Inc.
FDMT
0.757%
ImmunityBio, Inc.
IBRX
0.598%
Arcturus Therapeutics Holdings Inc.
ARCT
0.519%
Intellia Therapeutics, Inc.
NTLA
0.498%
OmniAb, Inc.
OABI
0.439%
Editas Medicine, Inc.
EDIT
0.322%
Ginkgo Bioworks Holdings, Inc.
DNA
0.242%
MacroGenics, Inc.
MGNX
0.221%